亮氨酸拉链4自身抗体:新型生殖细胞肿瘤与副肿瘤标志物
研究描述了一种新型生殖细胞肿瘤相关副肿瘤神经综合征(PNS)的生物标志物。在28例PNS患者血清中检出LUZP4-IgG,多数为男性,常见表现菱脑炎,最常见肿瘤为精原细胞瘤。LUZP4-IgG对生殖细胞肿瘤有高预测价值,并观察到抗原特异性T细胞反应。
要点
- LUZP4-IgG是生殖细胞肿瘤相关PNS的新型血清学标志物,对生殖细胞肿瘤有高预测价值。
- 最常见 presenting 表型为菱脑炎(17/28,61%),最常见肿瘤为精原细胞瘤(21/27,78%)。
- LUZP4-IgG阳性患者T细胞对重组LUZP4蛋白反应增强,支持CD8+ T细胞介导的细胞毒作用。
核心结论
- LUZP4-IgG是PNS的新型血清学标志物,对生殖细胞肿瘤有高预测价值。
- 抗原特异性T细胞反应支持CD8+ T细胞介导的细胞毒副肿瘤和抗肿瘤潜力。
研究设计与样本
- 回顾性分析生殖细胞肿瘤相关PNS患者的存档血清。
- 通过Western blot和质谱在人类睾丸癌细胞系TCam-2中鉴定共同自身抗原。
- 用重组蛋白Western blot、ELISA和基于细胞的实验确认抗原身份。
- 通过分析多种对照血清/脑脊液确认自身抗体特异性。
主要发现
- 28例患者血清中检出LUZP4-IgG,其中26例(93%)为男性。
- 神经系统症状起病中位年龄45岁(范围28-84)。
- ELISA中位滴度1:300(范围1:50至>1:6,400,正常值<1:50)。
- 18例(64%)同时检出kelchlike蛋白11-IgG。
- 最常见表现菱脑炎(17/28,61%),其他包括边缘性脑炎(5例,18%)、癫痫和/或脑炎(2例,7%)、运动神经元病/多神经根病(4例,14%)。
关键数值与推荐
- 癌症评估的PNS患者中最常见恶性肿瘤为精原细胞瘤(21/27,78%)。
- 全身FDG PET扫描发现的21例精原细胞瘤中9例(43%)为睾丸外。
- 两例女性患者均为卵巢畸胎瘤。
- 4例患者发现退行性睾丸生殖细胞肿瘤。
临床怎么用
- 对疑似副肿瘤神经综合征患者,尤其表现为菱脑炎者,可检测LUZP4-IgG辅助诊断。
- LUZP4-IgG阳性提示需积极筛查生殖细胞肿瘤,包括睾丸外和退行性病变。
- 该抗体对生殖细胞肿瘤有高预测价值,可指导肿瘤筛查策略。
局限性
- 研究基于存档血清,样本量有限(28例)。
- 未报告对照组中LUZP4-IgG的具体特异性数据。
- T细胞实验仅来自部分患者,机制结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was undertaken to describe a novel biomarker of germ cell tumor and associated paraneoplastic neurological syndrome (PNS). METHODS: Archival sera from patients with germ cell tumor-associated PNS were evaluated. We identified a common autoantigen in a human testicular cancer cell line (TCam-2) by Western blot and mass spectrometry. Its identity was confirmed by recombinant-protein Western blot, enzyme-linked immunosorbent assay (ELISA), and cell-based assay. Autoantibody specificity was confirmed by analyzing assorted control sera/cerebrospinal fluid. RESULTS: Leucine zipper 4 (LUZP4)-immunoglobulin G (IgG) was detected in 28 patients' sera, 26 of whom (93%) were men. The median age at neurological symptom onset was 45 years (range = 28-84). Median titer (ELISA) was 1:300 (1:50 to >1:6,400, normal value < 1:50). Coexistent kelchlike protein 11-IgG was identified in 18 cases (64%). The most common presenting phenotype was rhombencephalitis (17/28, 61%). Other presentations included limbic encephalitis (n = 5, 18%), seizures and/or encephalitis (n = 2, 7%), and motor neuronopathy/polyradiculopathy (n = 4, 14%). The most common malignancy among cancer-evaluated PNS patients was seminoma (21/27, 78%). Nine of the 21 seminomas detected by whole-body fluorodeoxyglucose positron emission tomography scan (43%) were extratesticular. Both female patients had ovarian teratoma. Regressed testicular germ cell tumors were found in 4 patients. Exposure of T-cell-dendritic-cell cocultures from chronic immunosuppression-naïve LUZP4-IgG-seropositive patients to recombinant LUZP4 protein evoked a marked increase in CD69 expression on both CD4+ and CD8+ T cells when compared to vehicle-exposed and healthy control cultures. INTERPRETATION: LUZP4-IgG represents a novel serological biomarker of PNS and has high predictive value for germ cell tumors. The demonstrated antigen-specific T-cell responses support a CD8+ T-cell-mediated cytotoxic paraneoplastic and antitumor potential. ANN NEUROL 2021;89:1001-1010.
引用
- Dubey D, Kryzer T, Guo Y, et al. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker. Ann Neurol. 2021. PMID: 33583072. doi:10.1002/ana.26050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。